Author/Authors :
Aletaha, Maryam Ophthalmic Research Center - Shahid Beheshti University of Medical Sciences, Tehran, Iran , Salour, Hossein Ophthalmic Research Center - Shahid Beheshti University of Medical Sciences, Tehran, Iran , Bagheri, Abbas Ophthalmic Research Center - Shahid Beheshti University of Medical Sciences, Tehran, Iran , Raffati, Nasrin Ophthalmic Research Center - Shahid Beheshti University of Medical Sciences, Tehran, Iran , Amouhashemi, Nassim Ophthalmic Research Center - Shahid Beheshti University of Medical Sciences, Tehran, Iran
Abstract :
Purpose: To report the long-term results of treatment of pediatric capillary hemangiomas
with oral propranolol.
Methods: Three infants, 3 to 4 months of age, with periocular capillary hemangiomas
were treated with oral propranolol solution (Inderal, 20mg/5ml) 2-3 mg/kg per day
divided in 2 doses. Propranolol was continued up to the end of the first year of life
and tapered over 2-3 weeks. All infants were followed for 20 months. Lesion size
and evolution were assessed during the follow-up period.
Results: Significant improvement was noted in all patients in the first 2 months of
therapy with slow and continuous effect throughout the follow-up period. No serious
complications were observed.
Conclusion: Oral propranolol can be used as a first line agent in children with
capillary hemangiomas
